Pfizer wants to give 15- and 16-year-olds AstraZeneca’s breakthrough cancer drug, and there’s a lot of resistance
This story originally ran on The Hill. This week, Pfizer asked the U.S. Food and Drug Administration to allow 16- and 17-year-olds to have the same access to AstraZeneca’s breakthrough cancer drug Imfinzi as…